Betoptic S
INDICATIONS
BETOPTIC S® Ophthalmic Suspension 0.25% is indicated for the treatment of elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.
DOSAGE AND ADMINISTRATION
Instill one drop of BETOPTIC S® Ophthalmic Suspension 0.25% in the affected eye twice daily. It may be used alone or in combination with other intraocular pressure lowering medications.
HOW SUPPLIED
Dosage Forms And Strengths
Bottle filled with 2.5, 5, 10, and 15 mL of 0.25% sterile ophthalmic suspension
BETOPTIC S® Ophthalmic Suspension 0.25% is supplied as follows: 2.5, 5, 10 and 15 mL in plastic ophthalmic DROP-TAINER® dispensers. Tamper evidence is provided with a shrink band around the closure and neck area of the DROP-TAINER package.
2.5 mL: NDC 0065-0246-20
5 mL: NDC 0065-0246-05
10 mL: NDC 0065-0246-10
15 mL: NDC 0065-0246-15
Storage and Handling
Store upright at 2°- 25°C (36°- 77°F). Shake well before using.
Alcon Laboratories, Inc. Fort Worth, Texas 76134. FDA Rev date: 5/8/2008
Generic Name: Betaxolol Hydrochloride Ophthalmic Suspension
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Glaucoma Laser Treatment
Glaucoma is a sight-stealing condition caused by pressure in the eye. Now patients are finding results through glaucoma laser treatment. See more WebMD Videos »
Betoptic S
Related Drugs
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.